Early-stage clinical trial demonstrates promise of intranasal influenza vaccine in generating broad immunity

Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) report encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad immune response against multiple strains of H5N1 “bird flu.”

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup